Valuation: Illumina, Inc.

Market Cap 29.4B 25.78B 23.77B 22.02B 41.76B 2,792B 42.46B 285B 111B 1,377B 110B 108B 4,769B P/E 2026 *
41.5x
P/E 2027 * 34.2x
Enterprise Value 29.92B 26.24B 24.19B 22.41B 42.5B 2,842B 43.21B 290B 113B 1,402B 112B 110B 4,854B EV / Sales 2026 *
6.55x
EV / Sales 2027 * 6.06x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.32%
1 week+9.06%
Current month+9.06%
1 month+18.14%
3 months+51.66%
6 months+27.72%
Current year+46.20%
1 week 184.4
Extreme 184.4
196.66
1 month 155.55
Extreme 155.55
196.66
Current year 112.65
Extreme 112.65
196.66
1 year 88
Extreme 88
196.66
3 years 68.7
Extreme 68.7
196.66
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer - 2026-01-31
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap.
06-29
Corvex Management LP
OtherCompany 0 0%
06-29Free

Director

167 0.0001%
06-29Free

Director

142 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.32%+9.06%+97.39%+4.60% 29.4B
-0.19%+3.04%+23.39%+0.56% 192B
-1.28%+7.45%-20.09%+28.98% 153B
+0.29%+1.95%-2.73%-16.69% 137B
+1.57%+6.14%-56.37%-13.37% 66.29B
-0.38%+4.82%+23.64%+5.05% 54.8B
+1.06%+3.07%-24.36%-28.90% 44.44B
-1.05%-0.03%+8.13%+41.94% 37.2B
+0.41%-1.27%+9.97%+12.09% 36.89B
+0.62%+12.76%-14.30%+1.83% 31.5B
Average -0.03%+4.63%+4.47%+3.61% 78.32B
Weighted average by Cap. -0.14%+4.33%+0.77%+3.28%

Financials

2026 *2027 *
Net sales 4.57B 4.01B 3.7B 3.42B 6.49B 434B 6.6B 44.25B 17.21B 214B 17.16B 16.79B 741B 4.83B 4.23B 3.9B 3.62B 6.85B 458B 6.97B 46.73B 18.18B 226B 18.12B 17.73B 783B
Net income 723M 634M 585M 542M 1.03B 68.7B 1.04B 7B 2.72B 33.88B 2.72B 2.66B 117B 869M 762M 703M 651M 1.23B 82.51B 1.25B 8.41B 3.27B 40.7B 3.26B 3.19B 141B
Net Debt 522M 458M 422M 391M 741M 49.57B 754M 5.05B 1.97B 24.45B 1.96B 1.92B 84.66B -160M -140M -129M -120M -227M -15.17B -231M -1.55B -602M -7.48B -600M -587M -25.91B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
26-07-07 US$191.76 -1.32% 2,582,498
26-07-06 US$194.33 +2.99% 2,103,315
26-07-02 US$188.68 +2.60% 2,941,733
26-07-01 US$183.89 +4.58% 2,140,193
26-06-30 US$175.83 -2.91% 1,762,379
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
194.33USD
Average target price
155.63USD
Spread / Average Target
-19.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock